Mobile

Immunosuppression without calcineurin inhibitors and with the use of everolimus (Certican) in HCV-infected liver transplant patients

Update Il y a 5 ans
Reference: EUCTR2007-006221-27

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

1. Comparison between study groups of the incidence and severity of histologically-proven rejection episodes. 2. Comparison between study groups of the incidence and severity of histologically-proven HCV recurrence.

Inclusion criteria

  • HCV cirrhosis

Links